COWELL® BMP is bone graft material based on the E.rhBMP-2 (E.Coli derived Recombinant Human Bone Morphogenetic Protein type 2), developed for the rst time in the world. COWELL® BMP is supported with 10 years of clinical data and over 40 studies.
BCP as a carrier allows maintenance of space
Cowellmedi is one of the few implant companies that has developed BMP, a bone formation inducing material. BMP development requires very high technology, and successful development means that Cowellmedi provides a complete implant solution.
COWELLMEDI is a leading company of dental healthcare products specializing in dental implants, regenerative biomaterials, dental instruments, and products for digitally guided implant processes
COWELLMEDI serves dental clinics, laboratories, healthcare institutes, governments and other related sites. COWELLMEDI offers a comprehensive selection of products and services, including education, technology trades, commercial consulting services, and other extensive solutions in implant dentistry.
With the development and localization of KOREA’S FIRST DENTAL IMPLANT in 1994, COWELLMEDI became the pioneer of Korea’s dental implant industry. COWELLMEDI received the Industrial Service Merit from the Korean government for its contribution to developing KOREA’S FIRST DENTAL IMPLANT (BIOPLANT™).
Over the past 30 years, COWELLMEDI’s continuous research and eorts have become the core of the country’s dental implant industry.
In 2010, COWELLMEDI successfully commercialized E.rhBMP-2 growth factor-based bone graft material for the first time in the world, drawing attention from the world once again. That was the driving force that developed COWELLMEDI into a global company in the biomedical Field
COWELLMEDI has been committed to innovating human life based on pushing the boundaries of the dental healthcare system and changing the way how the world treats the dental healthcare system
At COWELLMEDI, we are always thinking beyond products. We are pulling all our weight to realize our motto, “Help your daily practice superior,” by providing our best level services and the highest quality products, which have been clinical safety, efficacy, and reliability proven in multiple clinical cases and studies
Our motto-oriented services, products, and continuous research on innovation and clinical science networks have led us to become one of the greatest companies in the world biotechnology industry
We all know that no single product can suit all medical needs, biological situations, aesthetic requirements, and indications
Factors such as indications, age, hygienic and biological type, bone quality, and treatment plan require a sophisticated approach with dierently coordinated products
COWELL® Implant Solution consists of all proven materials for use in a variety of clinical cases for each specific indication, including diverse types of dental implants, instruments, regenerative biomaterials, and even E.rhBMP-2. All products are manufactured and managed under the highest quality control system.
COWELLMEDI is keen to develop relationships with new partners and does look forward to fully exploring better ways to collaborate to deliver mutual benefits. It is our belief that working on a partnership basis, you and we will ultimately prove to add value to your and our business and thereby enhance the customer and patient experience as a team.
Partnerships with dierent organizations are fundamental to our strategic priorities of growing a global business and delivering more products and services of value. COWELLMEDI has a diverse range of partnerships, and we are always looking for new opportunities.
One of the current key objectives of the partnership is to address partner consolidation and also to look at global opportunities for business expansion.
Should your business be as ambitious as ours and you believe you can add value for your customers, then we will be delighted for you to continue this process